Induction of oral tolerance in TGF-beta 1 null mice

Area of Science:

• Immunology
• Molecular Biology

Background:

• Oral tolerance, the immune system's unresponsiveness to ingested antigens, is crucial for preventing allergies.
• Previous research implicated transforming growth factor-beta 1 (TGF-beta 1) as a key mediator of oral tolerance, particularly at low antigen doses.

Purpose of the Study:

• To investigate the specific roles of TGF-beta 1 and other inhibitory cytokines in the induction of oral tolerance.
• To determine if TGF-beta 1 is essential for oral tolerance mediated by low-dose antigen administration.

Main Methods:

• Utilized TGF-beta 1 null mice and control groups.
• Administered varying doses of ovalbumin (OVA) orally (1 mg low dose, 10-20 mg high dose) for three days.
• Assessed the in vitro proliferative response of OVA-specific popliteal lymph node cells post-immunization.
• Quantified levels of IL-4, IL-10, and IFN-gamma in lymphocyte supernatants.

Main Results:

• TGF-beta 1 null mice fed high-dose OVA showed significant suppression of lymphocyte proliferation compared to controls.
• A significant, though weaker, suppression was observed in TGF-beta 1 null mice fed low-dose OVA.
• Lymphocytes from TGF-beta 1 null mice exhibited reduced levels of IL-4, IL-10, and IFN-gamma.

Conclusions:

• TGF-beta 1 contributes to oral tolerance, especially at higher antigen doses.
• Inhibitory cytokines, including TGF-beta 1, are not exclusively responsible for low-dose oral tolerance induction.
• The findings suggest that other immune regulatory mechanisms are involved in low-dose oral tolerance.